Abstract
Among 57 mutations in the peripheral myelin protein 22 gene (PMP22) identified so far in patients affected by Charcot-Marie-Tooth disease (CMT), only 8 have been shown to segregate with a mixed phenotype of CMT and hearing impairment. In this study, we report a new Ser1 12Arg mutation in thePMP22 gene, identified in a patient with early-onset CMT and slowly progressive hearing impairment beginning in the second decade of life. We suggest that the Ser1 12Arg mutation in thePMP22 gene might have a causative role in the early-onset CMT with hearing impairment. Thus, our study extends the spectrum of CMT phenotypes putatively associated withPMP22 gene mutations.
Similar content being viewed by others
References
Aarskog NK, Vedeler C, 2000. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107: 494–498.
Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, et al. 2002. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51: 190–201.
Cowchock FS, Duckett SW, Streletz LJ, Graziani LJ, Jackson LG, 1985. X-linked motor sensory neuropathy type-II with deafness and mental retardation: a new disorder. Am J Med Genet 20: 307–315.
De Weerdt CJ, Heerspink W, 1974. Family with Charcot-Marie-Tooth disease showing unusual biochemical-clinical and genetic features. Eur Neurol 12: 253–260.
Huehne K, Benes V, Thiel C, Kraus C, Kress W, Hoeltzenbein M, et al. 2003. Novel mutations in the Charcot-Marie-Tooth disease genesPMP22, MPZ, andGJB1. Hum Mut Mut 21: 100.
Ionasescu VV, Searby C, Greenberg SA, 1996. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of thePMP22 gene. J Med Genet 30: 1048–1049.
Jen J, Baloh RH, Ishiyama A, Baloh RW, 2005. Dejerine-Sottas syndrome and vestibular loss due to a point mutation in thePMP22 gene. Journal of the Neurological Sciences 237: 21–24.
Joo IS, Ki CS, Joo SY, Huh K, Kim JW, 2004. A novel point mutation inPMP22 gene associated with a familial case of Charcot-Marie-Tooth disease type 1A with sensorineural deafness. Neuromuscular Disorders 14: 325–328.
Kabzińska D, Korwin-Piotrowska T, Drechsler H, Drac H, Hausmanowa-Petrusewicz I, Kochański A, 2007. Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro 105 Thr mutation in theMPZ gene. Am J Med Genet 143A: 2196–2199.
Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, et al. 1996. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 14: 214–217.
Kovach MJ, Lin JP, Boyadjiev S, Campbell K, Mazzeo L, Herman K, et al. 1999. A unique point mutation in thePMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. Am J Hum Genet 64: 1580–1593.
Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219–232.
Naef R, Suter U, 1999. Impaired intracellular trafficking is a common disease mechanism ofPMP22 point mutations in peripheral neuropathies. Neurobiology of disease 6: 1–14.
Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. 1991. Duplication in chromosome 17p1 1.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromusc. Disord. 1: 93–101.
Sambuughin N, de Bantel A, McWilliams S, Sivakumar K, 2003. Deafness and CMT disease associated with a novel four amino acid deletion in thePMP22 gene. Neurology 60: 506–508.
Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B, 2004. Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 63: 733–735.
Suter U, Snipes GJ, 1995. Peripheral myelin protein 22: facts and hypotheses. Journal of Neuroscience Research 40: 145–151.
Tyson J, Ellis D, Fairbrother U, King RH, Muntoni F, Jacobs J, et al.1997. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain 120: 47–63.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabzińska, D., Sinkiewicz-Darol, E., Hausmanowa-Petrusewicz, I. et al. Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in thePMP22 gene, coexisting with a slowly progressive hearing impairment. J Appl Genet 51, 203–209 (2010). https://doi.org/10.1007/BF03195729
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03195729